Vivek Ra­maswamy's 'van­t' brain­chil­dren keep bear­ing fruit with Urovan­t's FDA nod for in­con­ti­nence med vibegron

Christ­mas has come ear­ly for Urovant Sci­ences as the for­mer Vivek Ra­maswamy out­fit scored an FDA ap­proval for its lead pro­gram.

The biotech’s over­ac­tive blad­der …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER